Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia - Wikidata - awgldk - TriplyDB

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

http://www.wikidata.org/entity/Q24528552

about

Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland Cardiovascular Cascade Genetic Testing: Exploring the Role of Direct Contact and Technology The genetics and screening of familial hypercholesterolaemia Genetics of coronary artery disease and myocardial infarction The Human Genome Project, and recent advances in personalized genomics Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis Construction of an odds model of coronary heart disease using published information: the Cardiovascular Health Improvement Model (CHIME)Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)Cascade Screening for Familial Hypercholesterolemia (FH)Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.Cascade testing in familial hypercholesterolaemia: how should family members be contacted?Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Genetics, genomics and proteomics in atherosclerosis research.Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review Reducing the burden of disease and death from familial hypercholesterolemia: a call to action Genetic screening by DNA technology: a systematic review of health economic evidence.The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?Commentary: What's so special about familial hypercholesterolaemia?A novel approach to screening for familial hypercholesterolemia in a large public venue.A qualitative study of patients' perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH).Genetic testing in the European Union: does economic evaluation matter?Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review.Management of inherited atherogenic dyslipidemias in children.Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.Genetics of familial hypercholesterolemia.Challenges in the care of familial hypercholesterolemia: a community care perspective.Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.

P2860

Q22330767-17887300-E175-447C-8BF4-60B1B711F54B Q24322584-BB8EC507-D82B-4D64-B9C2-4F35D513F8CD Q24658655-90B12B39-C7A3-4F33-AB3C-15E29060B4BE Q26740377-9D9E182B-7F0B-4F1C-A028-858861646CD5 Q26752300-1211C169-1FAC-4004-873A-9FC08FF11D83 Q26753081-3B30AD90-A5AE-44FA-952C-5F93A41915A4 Q26769994-6924005B-8866-42E0-B6FB-978ADA184FF4 Q26861372-E9D98770-F165-4EB1-AB36-F8746AA80F31 Q27024882-DEC95107-9C04-478D-A227-315E07762185 Q28248596-933E86C4-247D-4E1A-9343-10C03E11E7D5 Q33381870-82560136-5135-42D4-9CC9-0DBD8C8D420A Q33630769-5236D09D-40CF-4972-81B2-52ED0906F631 Q33919782-1BE804B4-1D1A-46B6-9611-000AF4D6155A Q34225128-D91775CC-DECA-4911-8BFA-1CB3090A79EA Q35549079-027B4E03-9EE6-433C-8597-50C7D42E9523 Q35583268-856D5443-DFB0-43A0-943D-6C56FD492D45 Q35602902-E0B02ADD-D73D-4DCD-A4BD-E519B267DB63 Q35771729-FE388ED6-4D84-446B-8195-CEDF79EE711C Q35808362-C75AD1E4-384B-4A1C-B46C-9DF6AF30C687 Q36013242-9D95B2AB-56F4-4527-8AEF-8554A0082958 Q36076131-0CC10EC1-EAA8-4938-ADC7-7B110CC66A90 Q36265225-6A1E0DDA-AE72-4E7E-A145-13D5ECC8260B Q36304418-53E79ADA-447B-4569-A9E6-0EABB8C75CF5 Q36381467-C1349A9F-062D-4A3F-A77B-67BC7C427936 Q36597619-63A3DA92-D46F-438B-8272-8D77F0E6B766 Q36925157-A4CDA98B-F2CD-4A3E-AF30-33C8B4BB71F4 Q36966952-94024535-37E1-48FD-B717-EDDA6A8D4AF4 Q37069579-4E12D45A-1AA6-462C-8848-6F9B6B916C1A Q37362741-6778FDE9-BADD-4CD8-9BA0-DFBCFA02778B Q37574714-90FC98AF-699A-4A27-9E72-FACACE6B9492 Q37574720-E884C0BA-7806-4601-A500-159B2C531E0B Q37877618-64E90A6F-05C0-4AE6-B4B5-B2ED5BCADB24 Q37986222-AFD013CC-04D1-4BE7-835F-874E8E651ABD Q38095645-A272276F-3710-48F6-8940-4669FD09D45B Q38097339-7D0B62BE-1C59-41BB-A18B-B0F9E440109C Q38217797-BEBAA4D0-11FC-4A6B-8CD3-EF146B84EB44 Q38364881-E7D1C5EC-4B69-4C64-9D5C-5FDFEF55FD7B Q38575066-BE08D0D6-9C23-41A9-87AA-7701FBDC4E2E Q38673894-9985E451-F593-4B49-818D-DA5F8FBFF639 Q38728768-9226294C-4313-49C6-9040-0B636D819B84

P2860

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

http://www.wikidata.org/entity/Q24528552

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@ast

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en-gb

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@nl

type

label

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@ast

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en-gb

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@nl

prefLabel

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@ast

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en-gb

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@nl

P1433

Q24528552-7CE61F76-1702-43D9-941A-0662663C9605

P1476

Q24528552-FEEED513-1881-496F-B360-B44414CD20E4

P2093

Q24528552-3E4B2C7B-A0F5-4918-82EA-1C646393CB57

Q24528552-5BB38269-95A3-4815-8A7E-F2BE071CE531

Q24528552-A84F8ED8-B95A-4579-992E-1364A1333DA5

Q24528552-CA24763D-7801-4C1D-B062-7C5396A209AE

P2860

Q24528552-20F14E92-181C-466E-ADD4-BBD3E6E8E4AB

Q24528552-37BFD6D1-FF72-4B5A-A6C2-319B5953E78E

Q24528552-3AC1740A-1FD0-42DD-8AED-241785D94B3C

Q24528552-3E767020-9693-469D-86DA-BFBD87044372

Q24528552-3F4C229F-3867-494A-88D7-FB7BA0D4B6AE

Q24528552-48E81FB1-BE31-4B2F-B792-7DE76097574D

Q24528552-50DF20D5-6E89-4B5E-B64F-A80F164D91B1

Q24528552-5825A5B0-6D86-4F20-94DC-C0B4382F4F8D

Q24528552-62E09D71-AA7C-4EF0-A743-8D5D09004343

Q24528552-705684F9-EA61-4F93-A5EC-0B1FA3D6706E

P304

Q24528552-B8F6EBA6-E3C7-4961-8612-7B33F108F831

P31

Q24528552-EBF9229F-82D4-4527-9398-0A8C20D0FA0E

P3181

Q24528552-2E35268B-1C9C-4CBD-8206-3C07A7D8719C

P356

Q24528552-482C291B-52C9-41A9-B204-9BF0D9CC9265

P407

Q24528552-C41ECB14-FF1C-415B-A754-100E4280E775

P433

Q24528552-AE90E17D-CD83-4FB3-B82B-4450ADA9C177

P478

Q24528552-F44D014E-246F-4FD3-B5FB-DF160E17C476

P50

Q24528552-B4D15B26-C605-42DF-BBE3-DC5C855F0034

Q24528552-D8882500-E417-4EF4-A127-DC963C257070

P577

Q24528552-59CAC183-43A1-442B-84FE-A3048A52A8A4

P5875

Q24528552-CF35EAA3-A625-46CF-A469-5EFC2503F20E

P698

Q24528552-E6C93999-A57D-47D4-A7B9-351D47CE4E9B

P921

Q24528552-174BEEF4-A023-4CA9-8F3B-B31C494DFCEF

P932

Q24528552-06969B74-C081-47C6-818A-2B059AE63690

P3181

P356

BMJ.324.7349.1303

P1433

P1476

Cost effectiveness analysis of ...... familial hypercholesterolaemia

@en

P2093

Dalya Marks

http://www.w3.org/2001/XMLSchema#string

H Andrew W Neil

http://www.w3.org/2001/XMLSchema#string

Helen Lambert

http://www.w3.org/2001/XMLSchema#string

Steve E Humphries

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Five-hundred life-saving interventions and their cost-effectiveness.

P304

1303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1271276

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.324.7349.1303

http://www.w3.org/2001/XMLSchema#string

P407

P433

7349

http://www.w3.org/2001/XMLSchema#string

P478

324

http://www.w3.org/2001/XMLSchema#string

P50

David Wonderling

Margaret Thorogood

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11332936

http://www.w3.org/2001/XMLSchema#string

P698

12039822

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

113765

http://www.w3.org/2001/XMLSchema#string